Héctor Martínez Gregorio

Dr. Héctor Martínez Gregorio


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2018 in Cancers
Verified
Journal Article
Open access
PDF file
RURosalia Quezada Urban
Rosalia Quezada Urban
CVClara Estela Díaz Velásquez
Clara Estela Díaz Velásquez
RGRina Gitler
Rina Gitler
MCMaría Patricia Rojo Castillo
María Patricia Rojo Castillo
MTMax Sirota Toporek
Max Sirota Toporek
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Hereditary breast and ovarian cancer syndrome (HBOC) represents 5–10% of all patients with breast cancer and is associated with high-risk pathogenic alleles in BRCA1/2 genes, but only for 25% of cases. We aimed to find new pathogenic alleles in a panel of 143 cancer-predisposing genes in 300 Mexican cancer patients with suspicion of HBOC and 27 high-risk patients with a severe family history of cancer, using massive parallel sequencing. We found pathogenic variants in 23 genes, including BRCA1/2. In the group of cancer patients 15% (46/300) had a pathogenic variant; 11% (33/300) harbored variants with unknown clinical significance (VUS) and 74% (221/300) were negative. The high-risk group had 22% (6/27) of patients with pathogenic variants, 4% (1/27) had VUS and 74% (20/27) were negative. The most recurrent mutations were the Mexican founder deletion of exons 9-12 and the variant p.G228fs in BRCA1, each found in 5 of 17 patients with alterations in this gene. Rare VUS with potential impact at the protein level were found in 21 genes. Our results show for the first time in the Mexican population a higher contribution of pathogenic alleles in other susceptibility cancer genes (54%) than in BRCA1/2 (46%), highlighting the high locus heterogeneity of HBOC and the necessity of expanding genetic tests for this disease to include broader gene panels.

9 December 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
LMLaura Moreno-Altamirano
Laura Moreno-Altamirano
KRKarina Robles-Rivera
Karina Robles-Rivera
Hugo Gildardo Castelán-SánchezHugo Gildardo Castelán-Sánchez
Hugo Gildardo Castelán-Sánchez
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Maria del Carmen IñarrituMaria del Carmen Iñarritu
Maria del Carmen Iñarritu
ANARMANDO NAVARRO
ARMANDO NAVARRO
The gut microbiota plays a vital role in various physical and physiological processes, including immune system regulation, neurotransmitter production, inflammatory response modulation, and the inhibition of pathogenic organisms. An imbalance in the microbial community, known as dysbiosis, has been associated with numerous health issues. Biological influences, health behaviors, socioeconomic determinants, and nutritional status can disrupt this balance. Objective: To evaluate the differences in the gut microbiota composition in medical students according to fiber intake, ultra-processed food (UPF) consumption, sex, body mass index, and socioeconomic status. Methods: A cross-sectional study was conducted with 91 medical students, and 82 fecal samples were analyzed. Sociodemographic and dietary data were collected via questionnaires, UPF consumption was assessed using the NOVA classification, and trained nutritionists performed anthropometry. DNA extraction and 16S rRNA sequencing were performed for the microbial analysis. Bioinformatics and statistical tests included the Dunn and Kruskal–Wallis tests, a PCoA analysis, PERMANOVA, ANOVA, Spearman’s rank correlation, and alpha and beta diversity metrics. Results: Dietary fiber intake strongly influences gut microbiota composition. Lower fiber intake was associated with a higher prevalence of Parabacteroides and Muribaculaceae. Prevotella was more prevalent in individuals with lower UPF intake, while Phascolarctobacterium was prevalent in those with higher UPF consumption. Significant differences were associated with sex and UPF consumption but not BMI or SES. Women consumed more UPF, which correlated with distinct gut microbiota profiles. Conclusions: This study highlights the significant impact of diet, particularly fiber intake and UPF, on gut microbiota composition, emphasizing the importance of dietary habits in maintaining gut health.

26 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MCMiguel Ruiz De La Cruz
Miguel Ruiz De La Cruz
Aldo H de la Cruz-MontoyaAldo H de la Cruz-Montoya
Aldo H de la Cruz-Montoya
ERErnesto Rojas-Jiménez
Ernesto Rojas-Jiménez
HGHéctor Martínez Gregorio
Héctor Martínez Gregorio
CVClara Estela Díaz Velásquez
Clara Estela Díaz Velásquez
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Epigenetics affects gene expression and contributes to disease development by alterations known as epimutations. Hypermethylation that results in transcriptional silencing of tumor suppressor genes has been described in patients with hereditary cancers and without pathogenic variants in the coding region of cancer susceptibility genes. Although somatic promoter hypermethylation of these genes can occur in later stages of the carcinogenic process, constitutional methylation can be a crucial event during the first steps of tumorigenesis, accelerating tumor development. Primary epimutations originate independently of changes in the DNA sequence, while secondary epimutations are a consequence of a mutation in a cis or trans-acting factor. Secondary epimutations have a genetic basis in cis of the promoter regions of genes involved in familial cancers. This highlights epimutations as a novel carcinogenic mechanism whose contribution to human diseases is underestimated by the scarcity of the variants described. In this review, we provide an overview of secondary epimutations and present evidence of their impact on cancer. We propose the necessity for genetic screening of loci associated with secondary epimutations in familial cancer as part of prevention programs to improve molecular diagnosis, secondary prevention, and reduce the mortality of these diseases.

12 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
HGHéctor Martínez Gregorio
Héctor Martínez Gregorio
ERErnesto Rojas-Jiménez
Ernesto Rojas-Jiménez
JMJavier César Mejía-Gómez
Javier César Mejía-Gómez
CDClara Díaz-Velásquez
Clara Díaz-Velásquez
RURosalia Quezada Urban
Rosalia Quezada Urban
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
In triple-negative breast cancer (TNBC), only 30% of patients treated with neoadjuvant chemotherapy achieve a pathological complete response after treatment and more than 90% die due to metastasis formation. The diverse clinical responses and metastatic developments are attributed to extensive intrapatient genetic heterogeneity and tumor evolution acting on this neoplasm. In this work, we aimed to evaluate genomic alterations and tumor evolution in TNBC patients with aggressive disease. We sequenced the whole exome of 16 lesions from four patients who did not respond to therapy, and took several follow-up samples, including samples from tumors before and after treatment, as well as from the lymph nodes and skin metastases. We found substantial intrapatient genetic heterogeneity, with a variable tumor mutational composition. Early truncal events were MCL1 amplifications. Metastatic lesions had deletions in RB1 and PTEN, along with TERT, AKT2, and CCNE1 amplifications. Mutational signatures 06 and 12 were mainly detected in skin metastases and lymph nodes. According to phylogenetic analysis, the lymph node metastases occurred at an early stage of TNBC development. Finally, each patient had three to eight candidate driving mutations for targeted treatments. This study delves into the genomic complexity and the phylogenetic and evolutionary development of aggressive TNBC, supporting early metastatic development, and identifies specific genetic alterations associated with a response to targeted therapies.

3 October 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
EMEric Monroy-Pérez
Eric Monroy-Pérez
JHJennefer Paloma Herrera-Gabriel
Jennefer Paloma Herrera-Gabriel
EOElizabeth Olvera-Navarro
Elizabeth Olvera-Navarro
LULorena Ugalde-Tecillo
Lorena Ugalde-Tecillo
LGLuis Rey García-Cortés
Luis Rey García-Cortés
GPGloria Luz Paniagua-Contreras
Gloria Luz Paniagua-Contreras
The increase in the number of hospital strains of hypervirulent and multidrug resistant (MDR) Pseudomonas aeruginosa is a major health problem that reduces medical treatment options and increases mortality. The molecular profiles of virulence and multidrug resistance of P. aeruginosa-associated hospital and community infections in Mexico have been poorly studied. In this study, we analyzed the different molecular profiles associated with the virulence genotypes related to multidrug resistance and the genotypes of multidrug efflux pumps (mex) in P. aeruginosa causing clinically critical infections isolated from Mexican patients with community- and hospital-acquired infections. Susceptibility to 12 antibiotics was determined using the Kirby–Bauer method. The identification of P. aeruginosa and the detection of virulence and efflux pump system genes were performed using conventional PCR. All strains isolated from patients with hospital-acquired (n = 67) and community-acquired infections (n = 57) were multidrug resistant, mainly to beta-lactams (ampicillin [96.7%], carbenicillin [98.3%], cefalotin [97.5%], and cefotaxime [87%]), quinolones (norfloxacin [78.2%]), phenicols (chloramphenicol [91.9%]), nitrofurans (nitrofurantoin [70.9%]), aminoglycosides (gentamicin [75%]), and sulfonamide/trimethoprim (96.7%). Most strains (95.5%) isolated from patients with hospital- and community-acquired infections carried the adhesion (pilA) and biofilm formation (ndvB) genes. Outer membrane proteins (oprI and oprL) were present in 100% of cases, elastases (lasA and lasB) in 100% and 98.3%, respectively, alkaline protease (apr) and alginate (algD) in 99.1% and 97.5%, respectively, and chaperone (groEL) and epoxide hydrolase (cif) in 100% and 97.5%, respectively. Overall, 99.1% of the strains isolated from patients with hospital- and community-acquired infections carried the efflux pump system genes mexB and mexY, while 98.3% of the strains carried mexF and mexZ. These findings show a wide distribution of the virulome related to the genotypic and phenotypic profiles of antibiotic resistance and the origin of the strains isolated from patients with hospital- and community-acquired infections, demonstrating that these molecular mechanisms may play an important role in high-pathogenicity infections caused by P. aeruginosa.

10 February 2023 in Frontiers in Genetics
Verified
Journal Article
Open access
CDClara Estela Díaz-Velásquez
Clara Estela Díaz-Velásquez
RGRina Gitler
Rina Gitler
AAAdriana Antoniano
Adriana Antoniano
RSRonny Kershenovich Sefchovich
Ronny Kershenovich Sefchovich
ACAldo Hugo De La Cruz-Montoya
Aldo Hugo De La Cruz-Montoya
FPFelipe Vaca Paniagua
Felipe Vaca Paniagua
Background: Individuals of Ashkenazi Jewish ancestry have been identified as having higher prevalence of specific pathogenic variants associated with susceptibility to specific rare and chronic diseases. In Mexico, the prevalence and composition of rare cancer predisposing germline variants in Ashkenazi Jewish individuals has not been evaluated.Aim and methods: We aimed to evaluate the prevalence of pathogenic variants by massive parallel sequencing in a panel of 143 cancer-predisposing genes in 341 women from the Ashkenazi Jewish community of Mexico, who were contacted and invited to participate in the study through the ALMA Foundation for Cancer Reconstruction. Pre- and posttest genetic counseling was given and a questionnaire on personal, gyneco-obstetric, demographic and lifestyle variables was conducted. From peripheral blood DNA, the complete coding region, and splicing sites of a panel of 143 cancer susceptibility genes, including 21 clinically relevant genes, were sequenced. The Mexican founder mutation BRCA1 ex9-12del [NC_000017.10(NM_007294):c. (825+1–826-1)_(4,589+1–4,590-1)del] was also evaluated.Results: Among study participants (mean age ±standard deviation: 47 ± 14) 15% reported a personal history of cancer (50/341). Fourteen percent of participants (48/341) were carriers of pathogenic and likely pathogenic variants distributed among seven high-risk genes (APC, CHEK2, MSH2, BMPR1A, MEN1, MLH1, and MSH6), whereas 18.2% (62/341) had variants of uncertain clinical significance in genes associated with breast and ovarian cancer susceptibility (list of genes with VUS). Pathogenic and likely pathogenic variants in 16 susceptibility genes with ambiguous or non-well-established risk association for cancer were detected in 17.6% (60/341) of participants. Sixty four percent of participants reported current alcohol consumption compared with the 39 percent prevalence of alcohol consumption in Mexican women. None of the participants carried the recurrent Ashkenazi and Mexican founder mutations in BRCA1 or BRCA2, but 2% (7/341) had pathogenic Ashkenazi Jewish founder variants in BLM.Conclusion: Our findings show a diverse pathogenic variant composition among the recruited individuals of Ashkenazi Jewish ancestry in Mexico consistent with being a high-risk population for genetic diseases, which warrants further investigation to adequately assess the burden of hereditary breast cancer in this group and implement appropriate preventative programs.